Capecitabine
XELODA
Nucleoside Metabolic Inhibitor
NADAC/unit
$0.3955
No Shortage
11 Manufacturers
22 ANDAs
Capecitabine interferes with DNA synthesis to slow cancer cell or viral replication.
vs. brand XELODA: Generic saves up to 96% per unit
Generic Manufacturers
ACCORD HEALTHCARE INCALKEM LABORATORIES LTDDR REDDYS LABORATORIES LTDEUGIA PHARMA SPECIALITIES LTDHETERO LABS LTD UNIT VMSN LABORATORIES PRIVATE LTDRELIANCE LIFE SCIENCES PVT LTDRISING PHARMA HOLDING INCSHILPA MEDICARE LTDTEVA PHARMACEUTICALS USA INCTEYRO LABS PRIVATE LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
